Please login or register first to view this content.
Infectious Diseases Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
FDA Panel Votes on Rezafungin for Treatment of Candidemia, Invasive Candidiasis
Uptake Low for COVID-19 Vaccine Boosters in Immunocompromised Adults
Seniors Had High Burden of RSV-Positive Respiratory Infection Before COVID-19
Algorithm Predicts Urinary Tract Infection Without Microscopy
Two Cases of New Drug-Resistant Gonorrhea Strain Reported in Massachusetts
Respiratory Virus Coinfection May Up SARS-CoV-2 Severity in Children Under 5
FDA Clears Test to Aid in Early Detection of Sepsis
Lack of Efficacy Ends Trial Evaluating Janssen’s HIV Vaccine Candidate
Convalescent COVID-19 Plasma Beneficial for Immunocompromised
Most Long COVID Resolves Within One Year for Mild Infections
Fluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19
December 2022 Recap: Drug Pipeline Updates
December 2022: Notable Drug Approvals
VV116 Noninferior to Nirmatrelvir-Ritonavir for COVID-19
FDA to Review 20-Valent Pneumococcal Conjugate Vaccine for Pediatric Use
Mpox Cases Reported in Cisgender Women
DAAs Less Likely for Hep C Patients With Alcohol Use Disorder
Discontinuation of Several HIV Medications Reported to FDA
